Lim D, Sreekanth V, Cox KJ, et al. Engineering designer beta cells with a CRISPR-Cas9 conjugation platform. Nature communications. 2020;11(1):4043. doi:10.1038/s41467-020-17725-0
Publications
Sreekanth V, Zhou Q, Kokkonda P, et al. Chemogenetic System Demonstrates That Cas9 Longevity Impacts Genome Editing Outcomes. ACS central science. 2020;6(12):2228-2237. doi:10.1021/acscentsci.0c00129
Long K, Alphey L, Annas G, et al. Core commitments for field trials of gene drive organisms. Science (New York, N.Y.). 2020;370(6523):1417-1419. doi:10.1126/science.abd1908
Kessler MD, Loesch DP, Perry JA, et al. De novo mutations across 1,465 diverse genomes reveal mutational insights and reductions in the Amish founder population. Proceedings of the National Academy of Sciences of the United States of America. 2020;117(5):2560-2569. doi:10.1073/pnas.1902766117
Pan-cancer analysis of whole genomes. Nature. 2020;578(7793):82-93. doi:10.1038/s41586-020-1969-6
Hazelbaker D, Beccard A, Angelini G, et al. A multiplexed gRNA piggyBac transposon system facilitates efficient induction of CRISPRi and CRISPRa in human pluripotent stem cells. Scientific reports. 2020;10(1):635. doi:10.1038/s41598-020-57500-1
Nehme R, Barrett L. Using human pluripotent stem cell models to study autism in the era of big data. Molecular autism. 2020;11(1):21. doi:10.1186/s13229-020-00322-9
Susco S, Arias-GarcÃa M, López-Huerta V, et al. FMR1 loss in a human stem cell model reveals early changes to intrinsic membrane excitability. Developmental biology. 2020;468(1-2):93-100. doi:10.1016/j.ydbio.2020.09.012
Molsberry S, Bjornevik K, Hughes KC, et al. Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson’s Disease. Journal of Parkinson’s disease. 2020;10(3):1011-1021. doi:10.3233/JPD-191896
Mitro SD, Larrabure-Torrealva GT, Sanchez SE, et al. Metabolomic markers of antepartum depression and suicidal ideation. Journal of affective disorders. 2020;262:422-428. doi:10.1016/j.jad.2019.11.061